Showing 13 of 33 recruiting trials for “takayasu-arteritis”
RecruitingNCT06011512 ↗
Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.
👨⚕️ Salome Kristensen, MD, PhD, Aalborg University Hospital📍 1 site📅 Started Aug 2023View details ↗
Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
👨⚕️ Merry Mazmanian, Dr., Santé Arménie French - Armenian Academic Research Organization FAARO📍 6 sites📅 Started Jun 2023View details ↗
Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency
👨⚕️ Ulla Feldt-Rasmussen, Professor, Rigshospitalet, Denmark📍 3 sites📅 Started Jun 2022View details ↗
RecruitingNCT05479448 ↗
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
👨⚕️ Thomas Daikeler, Prof. Dr. med., Department of Rheumatology University Hospital Basel📍 1 site📅 Started Jun 2022View details ↗
Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment
Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis
👨⚕️ Lindi Jiang, Ph.D., M.D., Department of Rheumatology in Zhongshan hospital, Fudan University📍 1 site📅 Started Nov 2021View details ↗
Abatacept for the Treatment of Giant Cell Arteritis
RecruitingNCT04664465 ↗
PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS
RecruitingNCT05865054 ↗
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
A Pilot Study in Severe Patients With Takayasu Arteritis.
RecruitingNCT03893136 ↗
The Registry Study of Takayasu Arteritis in East China
RecruitingNCT02964364 ↗
China Takayasu Arteritis Registry (CTA Registry)
RecruitingNCT04102930 ↗
Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →